Literature DB >> 16176194

Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients.

U R Kuppusamy1, M Indran, P Rokiah.   

Abstract

AIMS: Increased oxidative stress and oxidative damage are present in Type 2 diabetes mellitus (DM). The aim of this study was to assess the oxidative stress levels in the three major ethnic groups in Malaysia and to study the association between glycaemic control and oxidant-antioxidant levels in these patients.
METHODS: Oxidative indices and glycaemic control were assessed in 650 Type 2 DM patients and 280 healthy age-matched controls by known established methods.
RESULTS: Type 2 DM patients had significantly lower levels of antioxidant enzymes and non-enzymatic antioxidant (FRAP) and increased levels of HbA(1c), fasting blood glucose (FBG), malondialdehyde (MDA) and xanthine oxidase (XO) when compared with control subjects. Markers of oxidative stress were more apparent in Indian patients compared with Malay and Chinese patients. Correlation analysis of oxidant-antioxidant parameters as a function of HbA(1c) in each ethnic group revealed a strong association of HbA(1c) with oxidative indices.
CONCLUSIONS: The present study provides evidence for the possible contribution of XO to oxidative stress and the pathophysiology of diabetes. HbA(1c) remains an important marker of glycaemic control for the management of Type 2 DM, but other confounding factors that predispose or lead to oxidative stress should also be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176194     DOI: 10.1111/j.1464-5491.2005.01630.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  18 in total

1.  Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Authors:  Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; Madhusudan Barthwal; Arjun Kakrani; Sandy Chon; Amita Gupta; Jonathan E Golub; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

2.  Xanthine oxidoreductase activity is correlated with hepatic steatosis.

Authors:  Chisako Yagi; Yoshiki Kusunoki; Taku Tsunoda; Takayo Murase; Takashi Nakamura; Keiko Osugi; Mana Ohigashi; Akiko Morimoto; Akio Miyoshi; Miki Kakutani-Hatayama; Kae Kosaka-Hamamoto; Manabu Kadoya; Kosuke Konishi; Takuhito Shoji; Hidenori Koyama
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

3.  Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).

Authors:  Takashi Wada; Tatsuo Hosoya; Daisuke Honda; Ryusuke Sakamoto; Kazutaka Narita; Tomomitsu Sasaki; Daisuke Okui; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2018-01-25       Impact factor: 2.801

4.  Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.

Authors:  W S Waring; J A McKnight; D J Webb; S R J Maxwell
Journal:  Diabetologia       Date:  2007-10-10       Impact factor: 10.122

5.  Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial.

Authors:  Shi-Hui Cheng; Amin Ismail; Joseph Anthony; Ooi Chuan Ng; Azizah Abdul Hamid; Barakatun-Nisak Mohd Yusof
Journal:  BMC Complement Altern Med       Date:  2016-02-27       Impact factor: 3.659

6.  Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.

Authors:  Ayumi Nakatani; Shinya Nakatani; Eiji Ishimura; Takayo Murase; Takashi Nakamura; Mari Sakura; Yu Tateishi; Akihiro Tsuda; Masafumi Kurajoh; Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

7.  Chronic hyperglycemia may attenuate the serum-uric-acid-lowering effect of low-dose febuxostat in Japanese patients with type 2 diabetes mellitus.

Authors:  Yukihiro Bando; Hitomi Toyama; Hideo Kanehara; Azusa Hisada; Kazuhiro Okafuji; Daisyu Toya; Nobuyoshi Tanaka
Journal:  Diabetol Int       Date:  2016-01-14

8.  Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet.

Authors:  G Kanagasabapathy; S N A Malek; A A Mahmood; K H Chua; S Vikineswary; U R Kuppusamy
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-07       Impact factor: 2.629

9.  Effects of Omega-3 Fatty Acids Supplement on Antioxidant Enzymes Activity in Type 2 Diabetic Patients.

Authors:  Fatemeh Toorang; Abolghassem Djazayery; Mahmoud Djalali
Journal:  Iran J Public Health       Date:  2016-03       Impact factor: 1.429

10.  Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy.

Authors:  Dijana J Miric; Bojana M Kisic; Snezana Filipovic-Danic; Rade Grbic; Ilija Dragojevic; Marko B Miric; Dragana Puhalo-Sladoje
Journal:  J Diabetes Res       Date:  2016-11-14       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.